Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.

Brown GC, Brown MM, Lieske HB, Turpcu A, Rajput Y.

Int J Retina Vitreous. 2017 Feb 13;3:5. doi: 10.1186/s40942-016-0058-3. eCollection 2017.


Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation.

Wu B, Li J, Lin H, Wu H.

J Ophthalmol. 2016;2016:7689862. doi: 10.1155/2016/7689862. Epub 2016 Apr 20.


Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?

Lindsley K, Li T, Ssemanda E, Virgili G, Dickersin K.

Ophthalmology. 2016 Apr;123(4):884-97. doi: 10.1016/j.ophtha.2015.12.004. Epub 2016 Jan 22.


The cost-effectiveness of second-eye cataract surgery in the UK.

Cooper K, Shepherd J, Frampton G, Harris P, Lotery A.

Age Ageing. 2015 Nov;44(6):1026-31. doi: 10.1093/ageing/afv126. Epub 2015 Sep 26.


Serum MicroRNAs as Potential Biomarkers of AMD.

Szemraj M, Bielecka-Kowalska A, Oszajca K, Krajewska M, Goś R, Jurowski P, Kowalski M, Szemraj J.

Med Sci Monit. 2015 Sep 14;21:2734-42. doi: 10.12659/MSM.893697.


Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Parmeggiani F, Costagliola C, Semeraro F, Romano MR, Rinaldi M, Gallenga CE, Serino ML, Incorvaia C, D'Angelo S, De Nadai K, Dell'Omo R, Russo A, Gemmati D, Perri P.

Int J Mol Sci. 2015 Aug 20;16(8):19796-811. doi: 10.3390/ijms160819796.


Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements.

Bokinni Y, Shah N, Maguire O, Laidlaw DA.

Eye (Lond). 2015 Aug;29(8):1085-91. doi: 10.1038/eye.2015.94. Epub 2015 Jun 5.


Stem cell-based therapies for age-related macular degeneration: current status and prospects.

Mu Y, Zhao M, Su G.

Int J Clin Exp Med. 2014 Nov 15;7(11):3843-52. eCollection 2014. Review.


Simulation contact lenses for AMD health state utility values in NICE appraisals: a different reality.

Butt T, Crossland MD, West P, Orr SW, Rubin GS.

Br J Ophthalmol. 2015 Apr;99(4):540-4. doi: 10.1136/bjophthalmol-2014-305802. Epub 2014 Oct 28.


Ranibizumab, verteporfin photodynamic therapy or observation for the treatment of myopic choroidal neovascularization: cost effectiveness in the UK.

Claxton L, Malcolm B, Taylor M, Haig J, Leteneux C.

Drugs Aging. 2014 Nov;31(11):837-48. doi: 10.1007/s40266-014-0216-y.


A safety audit of the first 10 000 intravitreal ranibizumab injections performed by nurse practitioners.

Simcock P, Kingett B, Mann N, Reddy V, Park J.

Eye (Lond). 2014 Oct;28(10):1161-4. doi: 10.1038/eye.2014.153. Epub 2014 Jul 18.


Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.

Stein JD, Newman-Casey PA, Mrinalini T, Lee PP, Hutton DW.

Ophthalmology. 2014 Apr;121(4):936-45. doi: 10.1016/j.ophtha.2013.10.037. Epub 2014 Jan 7.


Anti-vascular endothelial growth factor in age-related macular degeneration: puzzle or a silent beginning!

Natarajan S.

Indian J Ophthalmol. 2013 Sep;61(9):475-8. doi: 10.4103/0301-4738.119421. No abstract available.


Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema.

Fong AH, Lai TY.

Clin Interv Aging. 2013;8:467-83. doi: 10.2147/CIA.S36811. Epub 2013 Apr 29. Review.


Mechanism of inflammation in age-related macular degeneration.

Parmeggiani F, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D'Angelo S, Perri P, De Palma P, De Nadai K, Sebastiani A.

Mediators Inflamm. 2012;2012:546786. doi: 10.1155/2012/546786. Epub 2012 Nov 7. Review.


Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration.

Feng XF, Constable IJ, McAllister IL, Isaacs T.

Int J Ophthalmol. 2011;4(1):85-8. doi: 10.3980/j.issn.2222-3959.2011.01.20. Epub 2011 Feb 18.


Supplemental Content

Support Center